With the rising diabetic population, the demand for glucose sensing devices has also been
on an increasing trend. Accordingly, the field of glucose biosensors for diabetes …

Disease diagnosis and monitoring using conventional healthcare services is typically
expensive and has limited accuracy. Wearable health technology based on flexible …

Implementations of wearable microneedle-based arrays of sensors for the monitoring of
multiple biomarkers in interstitial fluid have lacked system integration and evidence of robust …

Microneedle (MN) technologies have gained interest for biomedical applications, ranging
from drug delivery to sensing and tissue sampling in skin and internal organs. The …

Therapeutic drug monitoring is essential for dosing pharmaceuticals with narrow therapeutic
windows. Nevertheless, standard methods are imprecise and involve invasive/resource …

While over half a century has passed since the introduction of enzyme glucose biosensors
by Clark and Lyons, this important field has continued to be the focus of immense research …

Microneedles (MNs) are microscopic needles that are applied to the skin in a minimally
invasive way to facilitate transdermal drug delivery and/or uptake of interstitial fluid from the …

While the current smartwatches and cellphones can readily track mobility and vital signs, a
new generation of wearable devices is rapidly develo** to enable users to monitor their …

While wearable and mobile chemical sensors have experienced tremendous growth over
the past decade, their potential for tracking and guiding nutrition has emerged only over the …

Although interstitial fluid (ISF) is recognized as an important source of biomarkers, it is
difficult and time‐consuming to extract, thus limiting its use in medical diagnostic and clinical …